163 related articles for article (PubMed ID: 26595025)
21. Newer Immunosuppressants for Rheumatologic Disease: Preoperative Considerations.
Koh YR; Cummings KC
Rheum Dis Clin North Am; 2024 Aug; 50(3):545-557. PubMed ID: 38942584
[TBL] [Abstract][Full Text] [Related]
22. Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing.
Busti AJ; Hooper JS; Amaya CJ; Kazi S
Pharmacotherapy; 2005 Nov; 25(11):1566-91. PubMed ID: 16232020
[TBL] [Abstract][Full Text] [Related]
23. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gilliland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
J Arthroplasty; 2022 Sep; 37(9):1676-1683. PubMed ID: 35732511
[TBL] [Abstract][Full Text] [Related]
24. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gililland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
Arthritis Rheumatol; 2022 Sep; 74(9):1464-1473. PubMed ID: 35722708
[TBL] [Abstract][Full Text] [Related]
25. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gilliland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
Arthritis Care Res (Hoboken); 2022 Sep; 74(9):1399-1408. PubMed ID: 35718887
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.
Lee HH; Song IH; Friedrich M; Gauliard A; Detert J; Röwert J; Audring H; Kary S; Burmester GR; Sterry W; Worm M
Br J Dermatol; 2007 Mar; 156(3):486-91. PubMed ID: 17300238
[TBL] [Abstract][Full Text] [Related]
27. Lactation and Management of Postpartum Disease.
Bermas BL
Rheum Dis Clin North Am; 2017 May; 43(2):249-262. PubMed ID: 28390567
[TBL] [Abstract][Full Text] [Related]
28. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
J Arthroplasty; 2017 Sep; 32(9):2628-2638. PubMed ID: 28629905
[TBL] [Abstract][Full Text] [Related]
29. Rheumatologic Medication Use During Pregnancy.
Peterson EA; Lynton J; Bernard A; Santillan MK; Bettendorf B
Obstet Gynecol; 2020 May; 135(5):1161-1176. PubMed ID: 32282595
[TBL] [Abstract][Full Text] [Related]
30. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.
Furst DE; Keystone EC; Kirkham B; Kavanaugh A; Fleischmann R; Mease P; Breedveld FC; Smolen JS; Kalden JR; Burmester GR; Braun J; Emery P; Winthrop K; Bresnihan B; De Benedetti F; Dörner T; Gibofsky A; Schiff MH; Sieper J; Singer N; Van Riel PL; Weinblatt ME; Weisman MH
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii2-25. PubMed ID: 19022808
[No Abstract] [Full Text] [Related]
31. Genotypes, phenotypes and treatment with immunomodulators in the rheumatic diseases.
van Vollenhoven RF
J Intern Med; 2018 Sep; 284(3):228-239. PubMed ID: 29908080
[TBL] [Abstract][Full Text] [Related]
32. Perioperative management of selected problems in patients with rheumatic diseases.
Shaw M; Mandell BF
Rheum Dis Clin North Am; 1999 Aug; 25(3):623-38, ix. PubMed ID: 10467631
[TBL] [Abstract][Full Text] [Related]
33. A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting.
Rood JW; Du Toit R
S Afr Med J; 2020 Nov; 110(12):1231-1237. PubMed ID: 33403971
[TBL] [Abstract][Full Text] [Related]
34. Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.
Mitchell EL; Lau PKH; Khoo C; Liew D; Leung J; Liu B; Rischin A; Frauman AG; Kee D; Smith K; Brady B; Rischin D; Gibson A; Mileshkin L; Klein O; Weickhardt A; Arulananda S; Shackleton M; McArthur G; Östör A; Cebon J; Solomon B; Buchanan RR; Wicks IP; Lo S; Hicks RJ; Sandhu S
Eur J Cancer; 2018 Dec; 105():88-102. PubMed ID: 30439628
[TBL] [Abstract][Full Text] [Related]
35. The perioperative use of biologic agents in patients with rheumatoid arthritis.
Polachek A; Caspi D; Elkayam O
Autoimmun Rev; 2012 Dec; 12(2):164-8. PubMed ID: 22522087
[TBL] [Abstract][Full Text] [Related]
36. Biologic treatments for systemic rheumatic diseases.
Shirota Y; Illei GG; Nikolov NP
Oral Dis; 2008 Apr; 14(3):206-16. PubMed ID: 18282173
[TBL] [Abstract][Full Text] [Related]
37. [Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases].
Moiseev SV; Novikov PI; Semenkova EN; Strizhakov LA; Gulyaev SV; Yanushkevich TN; Nikiforova NV; Meshkov AD; Panasyuk VV; Sokorin YD; Taranova MV; Parfenova SA; Dubrovskaya LV; Zhabina ES; Kuznetsova EI; Lopatina IA; Bulanov NM; Mukhin NA
Ter Arkh; 2013; 85(5):37-43. PubMed ID: 23819337
[TBL] [Abstract][Full Text] [Related]
38. Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience.
Peña-Sagredo JL; Hernández MV; Fernandez-Llanio N; Giménez-Ubeda E; Muñoz-Fernandez S; Ortiz A; Gonzalez-Gay MA; Fariñas MC;
Clin Exp Rheumatol; 2008; 26(5):854-9. PubMed ID: 19032819
[TBL] [Abstract][Full Text] [Related]
39. [Postoperative complications in plastic surgery].
Vogt PM
Chirurg; 2009 Sep; 80(9):827-39. PubMed ID: 19669715
[TBL] [Abstract][Full Text] [Related]
40. Current perspectives on ophthalmic manifestations of childhood rheumatic diseases.
Palejwala NV; Yeh S; Angeles-Han ST
Curr Rheumatol Rep; 2013 Jul; 15(7):341. PubMed ID: 23686303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
